Humana Inc. $HUM Stake Trimmed by North Dakota State Investment Board

North Dakota State Investment Board trimmed its position in shares of Humana Inc. (NYSE:HUM) by 29.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,425 shares of the insurance provider’s stock after selling 2,213 shares during the quarter. North Dakota State Investment Board’s holdings in Humana were worth $2,070,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Humana in the second quarter valued at about $4,138,160,000. Pzena Investment Management LLC bought a new position in shares of Humana during the second quarter valued at about $1,749,014,000. Assenagon Asset Management S.A. lifted its position in shares of Humana by 20,126.8% during the third quarter. Assenagon Asset Management S.A. now owns 1,255,479 shares of the insurance provider’s stock valued at $479,053,000 after purchasing an additional 1,249,272 shares in the last quarter. Legal & General Group Plc purchased a new position in Humana during the second quarter worth about $329,760,000. Finally, Barrow Hanley Mewhinney & Strauss LLC purchased a new position in Humana during the second quarter worth about $314,922,000. Institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE HUM opened at $415.55 on Friday. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $456.50. The company has a 50-day simple moving average of $400.25 and a 200 day simple moving average of $308.01. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market capitalization of $49.90 billion, a PE ratio of 39.31, a price-to-earnings-growth ratio of 2.54 and a beta of 0.74.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue for the quarter was up 26.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.27 earnings per share. On average, research analysts predict that Humana Inc. will post 9.03 EPS for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 24th will be paid a dividend of $0.8850 per share. The ex-dividend date is Thursday, December 24th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s dividend payout ratio (DPR) is presently 33.49%.

Wall Street Analysts Forecast Growth

HUM has been the subject of a number of recent analyst reports. Wall Street Zen raised shares of Humana from a “hold” rating to a “buy” rating in a research report on Saturday, October 24th. Mizuho lifted their target price on shares of Humana from $468.00 to $495.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 13th. Morgan Stanley upgraded Humana from an “underweight” rating to an “overweight” rating in a research note on Friday, October 9th. Raymond James Financial raised Humana from a “market perform” rating to an “outperform” rating and set a $520.00 target price for the company in a report on Monday, October 12th. Finally, Monness Crespi & Hardt raised Humana to a “buy” rating in a report on Friday, October 9th. Twenty-one investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Humana currently has an average rating of “Moderate Buy” and a consensus target price of $453.30.

Humana Profile

Humana Inc is a health and well-being company that provides insurance products and health care services in the United States and Puerto Rico. The company’s primary business is government-sponsored health coverage, particularly Medicare Advantage plans for older adults, along with Medicare prescription drug plans, Medicaid coverage and certain commercial health insurance products.

Humana also operates CenterWell, its health care services platform focused on older adults. CenterWell includes primary care clinics, home health services and pharmacy services, with an emphasis on coordinated care, chronic-condition management and helping members receive care in lower-cost settings.

Founded in 1961 as a nursing-home company, Humana expanded into hospital operations before shifting its focus toward health insurance and related services.